AMYLASE POLYPEPTIDE

European patent · EP2432875 · In force

Register entry

Publication number
EP2432875
Application number
EP10723554
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 19, 2010
Published
Mar 28, 2012
Granted
Sep 7, 2016
Protection ends at the latest
May 18, 2030
Next annual fee due
May 31, 2026
IPC classes
C12P 19/14 (2006.01)
C12N 9/28 (2006.01)
Priority
EP 09160655 19.05.2009
US 179525 P 19.05.2009
PCT application
PCT/EP2010/056913 19.05.2010
PCT publication
WO2010/133644 25.11.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  2. Jun 3, 2024

    Address changed

    Owner
    DuPont Nutrition Biosciences ApS, Langebrogade 1, 1411 Copenhagen K, Denmark → International N&H Denmark ApS, Langebrogade 1, 1411 Copenhagen K, Denmark

    Published in Swissreg on 03.06.2024

  3. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  4. Jun 1, 2023

    Change

    Published in Swissreg on 01.06.2023

  5. Sep 16, 2016

    Agent entered

    Representative
    Marks & Clerk (Luxembourg) LLP, Dreikönigstrasse 31a, 8002 Zürich

    Published in Swissreg on 16.09.2016

  6. Sep 7, 2016

    Granted

    Published in Swissreg on 07.09.2016

Parties

Inventor

KRAGH, Karsten Matthias

DK-8260 Viby J, DK

KELLET-SMITH, Anja, Hemmingsen

DK-8000 Århus C, DK

MIKKELSEN, René

DK-8660 Skanderborg, DK

MEJLDAL, Rie

DK-8752 Østbirk, DK

JENNER, Rikke L. Bundgaard

DK-8471 Sabro, DK

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.